Invesco’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-20,901
| Closed | -$1.1M | – | 3891 |
|
|
2020
Q3 | $1.1M | Sell |
20,901
-865,841
| -98% | -$35.8M | ﹤0.01% | 2779 |
|
|
2020
Q2 | $29.5M | Buy |
886,742
+134,152
| +18% | +$4.27M | 0.01% | 1128 |
|
|
2020
Q1 | $20.5M | Buy |
752,590
+106,891
| +17% | +$2.98M | 0.01% | 1189 |
|
|
2019
Q4 | $12.7M | Buy |
645,699
+116,012
| +22% | +$1.86M | ﹤0.01% | 1633 |
|
|
2019
Q3 | $6.87M | Sell |
529,687
-92,661
| -15% | -$1.12M | ﹤0.01% | 1948 |
|
|
2019
Q2 | $7.75M | Sell |
622,348
-257,584
| -29% | -$3.42M | ﹤0.01% | 1917 |
|
|
2019
Q1 | $12.8M | Sell |
879,932
-129,214
| -13% | -$1.65M | ﹤0.01% | 1470 |
|
|
2018
Q4 | $11.1M | Sell |
1,009,146
-907,967
| -47% | -$12.6M | ﹤0.01% | 1480 |
|
|
2018
Q3 | $50.4M | Buy |
1,917,113
+607,990
| +46% | +$16.4M | 0.02% | 855 |
|
|
2018
Q2 | $26.8M | Sell |
1,309,123
-10,808
| -0.8% | -$232K | 0.01% | 1084 |
|
|
2018
Q1 | $24M | Sell |
1,319,931
-1,863,907
| -59% | -$31.1M | 0.01% | 1071 |
|
|
2017
Q4 | $44.4M | Sell |
3,183,838
-323,550
| -9% | -$4.37M | 0.02% | 828 |
|
|
2017
Q3 | $64.9M | Buy |
3,507,388
+18,673
| +0.5% | +$312K | 0.02% | 654 |
|
|
2017
Q2 | $59M | Sell |
3,488,715
-155,933
| -4% | -$2.37M | 0.02% | 693 |
|
|
2017
Q1 | $48.7M | Buy |
3,644,648
+21,645
| +0.6% | +$339K | 0.02% | 801 |
|
|
2016
Q4 | $54.5M | Sell |
3,623,003
-79,880
| -2% | -$1.06M | 0.02% | 728 |
|
|
2016
Q3 | $43.3M | Sell |
3,702,883
-67,029
| -2% | -$788K | 0.01% | 833 |
|
|
2016
Q2 | $40.7M | Buy |
3,769,912
+634,317
| +20% | +$6.54M | 0.02% | 847 |
|
|
2016
Q1 | $29M | Sell |
3,135,595
-626,633
| -17% | -$6.74M | 0.01% | 990 |
|
|
2015
Q4 | $55.8M | Buy |
3,762,228
+2,881,015
| +327% | +$48.2M | 0.02% | 714 |
|
|
2015
Q3 | $14.5M | Sell |
881,213
-31,384
| -3% | -$642K | 0.01% | 1286 |
|
|
2015
Q2 | $20.8M | Buy |
912,597
+787,263
| +628% | +$15.7M | 0.01% | 1194 |
|
|
2015
Q1 | $1.91M | Buy |
125,334
+12,312
| +11% | +$160K | ﹤0.01% | 2636 |
|
|
2014
Q4 | $1.36M | Sell |
113,022
-5,387
| -5% | -$61.6K | ﹤0.01% | 2767 |
|
|
2014
Q3 | $1.34M | Sell |
118,409
-1,222
| -1% | -$13.9K | ﹤0.01% | 2781 |
|
|
2014
Q2 | $1.45M | Sell |
119,631
-52,848
| -31% | -$624K | ﹤0.01% | 2789 |
|
|
2014
Q1 | $2.01M | Sell |
172,479
-34,248
| -17% | -$580K | ﹤0.01% | 2585 |
|
|
2013
Q4 | $3.65M | Buy |
206,727
+64,426
| +45% | +$1.08M | ﹤0.01% | 2242 |
|
|
2013
Q3 | $2.05M | Buy |
142,301
+20,146
| +16% | +$308K | ﹤0.01% | 2538 |
|
|
2013
Q2 | $1.84M | Buy |
+122,155
| New | +$1.61M | ﹤0.01% | 2444 |
|
Invesco's MNTA Position: Q4 2020 in Review
Invesco sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 20,901 shares — an estimated $1.1M sold.
Invesco first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $64.9M in Q3 2017. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Invesco reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Invesco sold 20,901 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.1M.
- Invesco first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Invesco's Momenta Pharmaceuticals, Inc. position peaked at $64.9M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Invesco's 13F filing for Q4 2020, filed 16 Feb 2021.